A J&J unit will try to convince the Third Circuit to throw out a verdict — and a record $1.6 billion judgment — seeking to hold it responsible for submitting nearly 160,000 false claims to the government through antiviral drug promotions, Daniel Seiden reports.
The case could force the appeals court to consider whether whistleblowers filing lawsuits against alleged fraudsters on the government’s behalf is constitutional. In this case, two whistleblowers sued in 2012, alleging that Janssen Products’ off-label drug promotion misled doctors, making the company’s reimbursement claims false.
But the Third Circuit ...
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Log in to keep reading or access research tools and resources.
CORAM, NY — A former New York City Department of Correction officer from Coram pleaded guilty to a charge of making a false statement in connection with a false workers’ compensation claim he made ...